Additionally, nucleotide-binding oligomerization domain-containing protein 2 (NOD2) mutation leads to a decrease in α-defensin production in Paneth cells in patients with Crohn’s disease [46] and the amount of immunoreactive α-defensin decreases in obese people [47]. Here, NOD2 is linked to Crohn disease.